IATT PMTCT Toolkit. Module 5 Tuberculosis / HIV Checklist‏

IATT

Background
In sub-Saharan Africa, tuberculosis (TB) is the leading cause of death among people living with HIV (PLHIV), and parental deaths due to TB have resulted in almost 10 million orphan children worldwide by 2009. As the number of women living with HIV has increased, TB incidence among women in their childbearing years has also increased, leading to an increased risk of TB- and HIV-related morbidity and mortality for mothers and their children. In high HIV prevalence settings, such as sub-Saharan Africa, TB is reported to cause up to 15% of all maternal mortality. Maternal TB presents a risk not only to the pregnant woman, but also to her newborn and young children. HIV-infected pregnant women with TB disease are at increased risk of transmitting both TB and HIV to their infants. Focusing efforts on prevention, identification, and treatment of TB disease in HIV-infected pregnant women has the potential to improve health outcomes not just for women, but for their children as well.

Purpose and Intended Use of the Tool
In countries implementing lifelong antiretroviral treatment (ART) for pregnant and breastfeeding women (commonly referred to as “Option B+”), prevention of mother-to-child HIV transmission (PMTCT) sites will effectively function as HIV care and treatment centers for women and, often, for their children and families as well. As national PMTCT programs are revising guidelines, training curricula, and recording and reporting tools for Option B+, this is a unique opportunity to incorporate TB/HIV activities into program planning efforts. TB/HIV services should also be integrated into the broader continuum of maternal, newborn, and child (MNCH) settings, including community and facility-based sites providing postpartum services, immunizations, and other child health interventions. In order to reduce the impact of TB among mothers and children, it is essential that PMTCT and MNCH programs adopt the World Health Organization (WHO) recommendations for TB/HIV, including implementing TB intensified case finding (e.g. screening of all PLHIV and systematic evaluation of contacts of people with potentially infectious TB), infection control measures, and isoniazid preventive therapy (IPT).

Audience
This checklist is intended to assist national program managers, clinic administrators, and other public health officials as they work towards integration of TB/HIV services in PMTCT and MNCH programs.

July 6, 2015
Year of publication
2015
Resource types
Guidelines and Policies
Tags
tuberculosis, HIV-TB co-infection, maternal mortality, HIV-positive pregnant women, lifelong antiretroviral antiretroviral therapy, ARVs, ART, treatment, HIV prevention, antiretroviral drugs, PMTCT, children, women, option B+, prevention of mother-to-child HIV transmission, HIV care and treatment services, program planning, MNCH, maternal; newborn and child health, integrated services

Similar Resources

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

The Road Map was prepared through a consultative process that brought together more than 40 countries and organizations, including civil society organizations, networks of people living with HIV, faith-based organizations, networks of key populations and international organizations and…

PrEP could complement established HIV prevention strategies for pregnant and breastfeeding women as part of a comprehensive package to reduce HIV infections among women and transmission from mothers to infants in settings with high HIV incidence.

We conducted a retrospective study to investigate the effectiveness of an mHealth messaging intervention aiming to improve maternal health and HIV outcomes.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

Option B+ for prevention of mother-to-child transmission (PMTCT) specifies treating all HIV-positive women with antiretroviral therapy (ART) regardless of CD4 count. This simplified approach enhances countries' capacity to reach national HIV targets and contribute to the global 90-90-90 goals.…

Reducing HIV mother-to-child transmission (MTCT) is critical to ending the HIV pandemic. Reports suggest that herpes simplex virus-2 (HSV-2), a common coinfection in HIV-infected individuals, is associated with increased MTCT, but results have been conflicting.

Approximately 1.4 million women living with HIV become pregnant every year. Most women use antiretroviral therapy, to reduce the risk of vertical transmission or for personal health reasons.